A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

Clinical trial NCT06418659 · RECRUITING

Trial details

NCT number: NCT06418659
Sponsor: Shanghai Changzheng Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2024-10-12
Primary completion: 2026-04-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.